Defensin

The name 'defensin' was coined in the mid-1980s, though the proteins have been called 'Cationic Antimicrobial Proteins,' 'Neutrophil peptides,' 'Gamma thionins' amongst others. Proteins called 'defensins' are not all evolutionarily related to one another. Instead fall into two broad superfamilies, each of which contains multiple families. One superfamily, the trans-defensins, contains the defensins found in humans and other vertebrates, as well as some invertebrates. The other superfamily, cis-defensins, contains the defensins found in invertebrates, plants, and fungi. The superfamilies and families are determined by the overall tertiary structure, and each family usually has a conserved pattern of disulphide bonds. All defensins form small and compact folded structures, typically with a high positive charge, that are highly stable due to the multiple disulphide bonds. In all families, the underlying genes responsible for defensin production are highly polymorphic. Trans-defensins Vertebrate defensins are primarily α-defensins and β-defensins. Some primates additionally have the much smaller θ-defensins. In general, both α- and β-defensins are encoded by two-exon genes, where the first exon encodes for a hydrophobic leader sequence (removed after translation) and the cysteine-rich sequence (the mature peptide). The disulfide linkages formed by the cysteines have been suggested to be essential for activities related to innate immunity in mammals, but are not necessarily required for antimicrobial activity. Theta defensins form a single beta-hairpin structure and represent a distinct group. Only alpha and beta-defensins are expressed in humans. Although the most well-studied defensins are from vertebrates, a family of trans-defensins called 's' are found in molluscs, arthropods and lancelets. Other invertebrates known to produce defensins from this protein superfamily include molluscs, annelids and cnidaria. Plant defensins were discovered in 1990 and have subsequently been found in most plant tissues with antimicrobial activities, with both antifungal and antibacterial examples. They have been identified in all major groups of vascular plants, but not in ferns, mosses or algae. Studied examples mainly have anti-bacterial activities and have been found in both main divisions of fungi (Ascomycota and Basidiomycota), as well as in the more basal groups of Zygomycota and Glomeromycota. Bacterial defensins have also been identified, but are by far the least studied. They include variants with only four cysteines, whereas defensins from eukaryote defensins almost all have six or eight. Related defensin-like proteins In addition to the defensins involved in host defence, there are a number of related Defensin-Like Peptides (DLPs) that have evolved to have other activities. Toxins There appear to have been multiple evolutionary recruitments of defensins to be toxin proteins used in the venoms of animals; they act via a completely different mechanism to their antimicrobial relatives, from binding directly to ion channels to disrupting nerve signals. Examples include the crotamine toxin in snake venom, many scorpion toxins, some sea anemone toxins, Signalling In vertebrates, some α- and β-defensins are involved in signalling between the innate immune and adaptive immune systems. In plants, a specialised family of DLPs is involved in signalling to detect if self-pollination has occurred and induce self-incompatibility to prevent inbreeding. Enzyme inhibitors Some antimicrobial defensins also have enzyme inhibitory activity, and some DLPs function primarily as enzyme inhibitors, acting as antifeedants (discouraging animals from eating them). == Function ==

In immature marsupials, because their immune system is underdeveloped at the time of birth, defensins play a major role in defense against pathogens. They are produced in the milk of the mother as well as by the young marsupial in question. In human breast milk, defensins play a central role in neonate immunity. The human genome contains theta-defensin genes, but they have a premature stop codon, hampering their expression. An artificial human theta-defensin, retrocyclin, was created by 'fixing' the pseudogene, and it was shown to be effective against HIV and other viruses, including herpes simplex virus and influenza A. They act primarily by preventing these viruses from entering their target cells. Also interesting is the effect of alpha-defensins on the exotoxin produced by anthrax (Bacillus anthracis). Chun Kim et al. showed how anthrax, which produces a metalloprotease lethal factor (LF) protein to target MAPKK, is vulnerable to human neutrophil protein-1 (HNP-1). This group showed HNP-1 to behave as a reversible noncompetitive inhibitor of LF. They have generally been considered to contribute to mucosal health; however, it is possible that these peptides can be considered biological factors that can be upregulated by bioactive compounds present in human breast milk. In this sense, the intestinal production of antimicrobial peptides as hBD2 and hBD4 by trefoil from milk might play an important role on neonate colonization, thereby enhancing the immune response of newborns against pathogens with which they may come in contact. == Pathology ==

The alpha defensin peptides are increased in chronic inflammatory conditions. Alpha defensin are increased in several cancers, including colorectal cancer. An imbalance of defensins in the skin may contribute to acne. A reduction of ileal defensins may predispose to Crohn's disease. In one small study, a significant increase in alpha defensin levels was detected in T cell lysates of schizophrenia patients; in discordant twin pairs, unaffected twins also had an increase, although not as high as that of their ill siblings. The authors suggested that alpha-defensin levels might prove a useful marker for schizophrenia risk. Defensins are found in the human skin during inflammatory conditions like psoriasis and also during wound healing. ==Applications==

Defensins At present, the widespread spread of antibiotic resistance requires the search and development of new antimicrobial drugs. From this point of view, defensins (as well as antimicrobial peptides in general) are of great interest. It was shown that defensins have pronounced antibacterial activity against a wide range of pathogens. In addition, defensins can enhance the effectiveness of conventional antibiotics. Similar molecules, such as brilacidin, are being developed as antibiotics, anti-inflammatories for oral mucositis, and antifungals, especially for candidiasis. == See also ==